UK Vision Strategy claims sight loss is set to double

Article

Sight loss could double in the UK by the year 2050, according to predictions from eye health service UK Vision Strategy.

Sight loss could double in the UK by the year 2050, according to predictions from eye health service UK Vision Strategy.

Currently, one in five people aged 75 years and above have developed sight loss, compared to one in two people aged 90 years and above. Experts from the eye care and sight loss divisions are planning to identify improvements in diagnosis and find better treatments to avoid the predicted significant increase.

The UK Vision Strategy is a segment of the World Health Organisation's VISION 2020 initiative, which aspires to eliminate sight loss by the year 2020.

Chairperson of the UK Vision UK Vision Strategy and Chief Executive of Royal National Institute of Blind People, Lesley-Anne Alexander said, "Looking after your eyes by having regular checks is just as important as monitoring your blood pressure or paying a routine visit to the dentist. Problem teeth can usually be repaired or replaced but with eyes, the solution is rarely so simple. Whatever your age or health situation, if you haven't had your eyes checked recently, take action now and you could well prevent sight loss problems in later life".

Chairperson of VISION 2020 UK Nick Astbury, said, " Losing your sight should never become a naturally accepted part of getting older. Over half of all sight loss in this country can be avoided if it is picked up early and treated. Taking regular exercise, eating a healthy diet and stopping smoking is also vital for keeping your eyes healthy".

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.